Cargando…
Glucosamine inhibits extracellular matrix accumulation in experimental diabetic nephropathy
INTRODUCTION: Glucosamine, the intermediate metabolite of the hexosamine biosynthesis pathway (HBP), is widely used as a supplementary drug in patients with osteoarthritis. However, its consequences in such patients concomitantly suffering from diabetic nephropathy is unknown. METHODS: The aim of th...
Autores principales: | Teuma, Loic, Eshwaran, Rachana, Tawokam Fongang, Ulrich, Wieland, Johanna, Shao, Feng, Lagana, Maria Luisa, Wang, Yixin, Agaci, Ane, Hammes, Hans-Peter, Feng, Yuxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751334/ https://www.ncbi.nlm.nih.gov/pubmed/36532524 http://dx.doi.org/10.3389/fnut.2022.1048305 |
Ejemplares similares
-
Glucosamine protects against neuronal but not vascular damage in experimental diabetic retinopathy
por: Eshwaran, Rachana, et al.
Publicado: (2021) -
Contribution of the hexosamine biosynthetic pathway in the hyperglycemia-dependent and -independent breakdown of the retinal neurovascular unit
por: Wang, Yixin, et al.
Publicado: (2023) -
Involvement of NDPK-B in Glucose Metabolism-Mediated Endothelial Damage via Activation of the Hexosamine Biosynthesis Pathway and Suppression of O-GlcNAcase Activity
por: Chatterjee, Anupriya, et al.
Publicado: (2020) -
Sufficient Cav-1 levels in the endothelium are critical for the maintenance of the neurovascular unit in the retina
por: Wang, Yixin, et al.
Publicado: (2023) -
Role of the Ang2–Tie2 Axis in Vascular Damage Driven by High Glucose or Nucleoside Diphosphate Kinase B Deficiency
por: Chatterjee, Anupriya, et al.
Publicado: (2020)